News

In Pakistan, Epicentre is conducting a study to better understand how new, all oral, shorter treatments for multidrug-resistant/rifampicin‑resistant t...

The AMoCo* study continues to highlight persistent challenges related to abortion care and complications in fragile and conflict-affected settings. Co...

With cholera epidemics on the rise and global vaccine stocks remaining under pressure, in 2024 the WHO prequalified a new oral cholera vaccine, Euvich...

At the World Conference on Lung Health held from November 18 to 21, 2025, in Copenhagen, Médecins Sans Frontières (MSF) and Epicentre have revealed th...

To gain a better understanding of the issues at stake in terms of HIV prevention and action, Jihane Ben-Farhat has carried out an in-depth analysis of...

In Mali, breast and cervical cancer account for nearly half of all cancers in women, with a very high mortality rate of 60% (1). Faced with this burde...

In some regions of Kenya, more than one person in five is now affected by hypertension (1). However, treatment is still too limited, despite the intro...

A new study led by researchers at the Ineos Oxford Institute for antimicrobial research (IOI), in collaboration with Epicentre, has found that antimic...

In 2024 alone, nearly 40,000 women were treated by MSF teams in North Kivu province after suffering sexual violence — a record high. Since January 202...

A recent retrospective mortality survey of Médecins Sans Frontières (MSF) staff and their families reveals the appalling death rate of Israel’s all-ou...